All news

A zero-price warrant option could add shares following China SXT (SXTC)'s completed offering.

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

China SXT Pharmaceuticals, Inc. (SXTC) successfully completed a registered direct offering of 8 million units at

Read original source

SXTC company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.